ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹14 Cr | ₹57 Cr | ₹42 Cr | ₹43 Cr | ₹45 Cr |
What is the latest Contingent Liabilities ratio of ORCHID PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹45 Cr |
How is Contingent Liabilities of ORCHID PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -75.26 | |
| Mar2024 | ₹57 Cr | 34.12 | |
| Mar2023 | ₹42 Cr | -0.94 | |
| Mar2022 | ₹43 Cr | -4.96 | |
| Mar2021 | ₹45 Cr | - | |
Compare Contingent Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,109.8 Cr | 8.1% | 18.5% | 40.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 8.1% |
18.5% |
40.6% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses